Life and Death in the Microcirculation: a Role for Angiotensin II

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Microcirculation

• Publication date

  1998-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1549-8719.1998.tb00060.xPMID 9789251
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reversal of microvascular rarefaction and reduced renal mass hypertension.

  1997cited by this paper
• Rapid microvessel rarefaction with elevated salt intake and reduced renal mass hypertension in rats.

  1996cited by this paper
• Angiotensin II type 2 receptor mediates programmed cell death.

  1996cited by this paper
• Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide.

  1996cited by this paper
• Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension

  1996cited by this paper
• Opposing actions of angiotensin II on microvascular growth and arterial blood pressure.

  1996cited by this paper
• Angiogenic growth factor mRNA responses in muscle to a single bout of exercise.

  1996cited by this paper
• Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension.

  1996cited by this paper
• The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.

  1995cited by this paper
• Proposed update of angiotensin receptor nomenclature.

  1995cited by this paper
• Regulation of PDGF-A: a possible mechanism for angiotensin II-induced vascular growth.

  1995cited by this paper
• Vascular remodeling in hypertension: role of autocrine-paracrine factors.

  1995cited by this paper
• Angiotensin II mediates a sustained rise in nuclear and cytoplasmic calcium via multiple receptor subtypes.

  1995cited by this paper
• Characterization of a functional angiotensin IV receptor on coronary microvascular endothelial cells.

  1995cited by this paper
• Hemodynamic and microcirculatory changes during development of renal hypertension.

  1995cited by this paper
• Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV.

  1995cited by this paper
• PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors

  1994cited by this paper
• Angiotensin II induces TIMP-1 production in rat heart endothelial cells.

  1994cited by this paper
• Angiotensin II induces TGF-beta 1 production in rat heart endothelial cells.

  1994cited by this paper
• Agonistic and antagonistic properties of angiotensin analogs at the AT2 receptor in PC12W cells.

  1993cited by this paper
• Cardiovascular actions of angiotensin(1-7).

  1993cited by this paper
• Slow developing pressor effect of angiotensin II and vascular structure.

  1993cited by this paper
• Vascular renin-angiotensin system and vascular protection.

  1993influential reference
• Losartan prevents salt-induced hypertension in reduced renal mass rats.

  1993cited by this paper
• Subpressor angiotensin II is a bifunctional growth factor of vascular muscle in rats

  1992cited by this paper
• Salt intake and angiotensin II alter microvessel density in the cremaster muscle of normal rats.

  1992cited by this paper
• Expression of angiotensin II AT2 receptors in the rat skin during experimental wound healing.

  1992cited by this paper
• Effect of microvascular rarefaction on tissue oxygen delivery in hypertension.

  1992cited by this paper
• Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall.

  1991influential reference
• Pharmacology of DuP 532, a selective and noncompetitive AT1 receptor antagonist.

  1991cited by this paper
• Pressure-independent arteriolar rarefaction in hypertension.

  1991cited by this paper
• Angiotensin II induces endothelium-dependent vasodilation of rat cerebral arterioles.

  1990cited by this paper
• Captopril Reduces Aortic and Microvascular Growth in Hypertensive and Normotensive Rats

  1990cited by this paper
• Structural Changes During Microvascular Rarefaction in Chronic Hypertension

  1990cited by this paper
• Microvessel Changes in Hypertension Measured by Griffonia simplicifolia I Lectin

  1990cited by this paper
• Microvascular rarefaction and tissue vascular resistance in hypertension.

  1989cited by this paper
• Hemodynamics and Microcirculatory Alterations in Reduced Renal Mass Hypertension

  1989cited by this paper
• Microvascular rarefaction in spontaneously hypertensive rat cremaster muscle.

  1981cited by this paper
• Effects of varying sodium intake on blood pressure and renin-angiotensin system in subtotally nephrectomized rats.

  1976influential reference

• Computational screening of potential AT1R inhibitors from Nigella sativa for diabetic-hypertensive therapy

  2024cites this paper
• Endocrine Effects of Simulated Complete and Partial Aortic Occlusion in a Swine Model of Hemorrhagic Shock.

  2018cites this paper
• Does a Better Perfusion of Deconditioned Muscle Tissue Release Chronic Low Back Pain?

  2018cites this paper
• Roles of LOX-1 in microvascular dysfunction.

  2016cites this paper
• Salt, Angiotensin II, Superoxide, and Endothelial Function.

  2015cites this paper
• Angiotensin AT2 receptor activates the cyclic-AMP signaling pathway in eel.

  2013cites this paper
• Excellence Award in Hypertension Research Vascular Remodeling in Hypertension Mechanisms and Treatment

  2012cites this paper
• Vascular Remodeling in Hypertension: Mechanisms and Treatment

  2012cites this paper
• Microvascular Responses to Cardiovascular Risk Factors

  2010cites this paper
• Chapter 15 – Vascular Remodeling and Rarefaction in Hypertension

  2007cites this paper
• The renin angiotensin system in the regulation of angiogenesis.

  2007cites this paper
• Angiogenic protection from focal ischemia with angiotensin II type 1 receptor blockade in the rat.

  2005cites this paper
• Reverse transcription and polymerase chain reaction: principles and applications in dentistry.

  2004cites this paper
• Conversion of renin substrate tetradecapeptide to angiotensin II by rat MAB elastase-2.

  2004cites this paper
• Microvascular Remodeling: A Complex Continuum Spanning Angiogenesis to Arteriogenesis

  2003cites this paper
• [Influence of angiotensin I on angiogenesis in vitro in the rat].

  2003cites this paper
• Application of Physiological Genomics to the Microcirculation

  2002cites this paper
• The Inflammatory Aspect of the Microcirculation in Hypertension: Oxidative Stress, Leukocytes/Endothelial Interaction, Apoptosis

  2002cites this paper
• Angiotensin II stimulates migration of retinal microvascular pericytes: involvement of TGF-beta and PDGF-BB.

  2002cites this paper
• Structural Adaptation of Microvascular Networks and Development of Hypertension

  2002cites this paper
• Microvascular angiogenesis and the renin-angiotensin system

  2002cites this paper
• Abnormal Iron Deposition in Renal Cells in the Rat with Chronic Angiotensin II Administration

  2002cites this paper
• [Hypertension and microcirculation].

  2002cites this paper
• Molecular Cloning and Sequencing of the cDNA for Rat Mesenteric Arterial Bed Elastase-2, an Angiotensin II–Forming Enzyme

  2002cites this paper
• Life and Death Cell Labeling in the Microcirculation of the Spontaneously Hypertensive Rat

  2001cites this paper
• Angiotensin converting enzyme inhibition in the microcirculation

  2001cites this paper
• ANG II is required for optimal overload-induced skeletal muscle hypertrophy.

  2001cites this paper
• Protection against ischemia: a physiological function of the renin-angiotensin system.

  2001cites this paper
• Coronary microvasculature alteration in hypertensive rats. Effect of treatment with a diuretic and an ACE inhibitor.

  2001cites this paper
• Reinforcement of arteriolar myogenic activity by endogenous ANG II: susceptibility to dietary salt.

  2000cites this paper
• AT(1) receptor inhibition does not reduce arterial wall hypertrophy or PDGF-A expression in renal hypertension.

  2000cites this paper
• Effect of antihypertensive drugs on the myocardial microvessels in rats with nitric oxide blockade.

  2000cites this paper
• Angiotensin II and retinal pericytes migration.

  1999cites this paper
• Gender-specific protection from microvessel rarefaction in female hypertensive rats.

  1998cites this paper